GSK, U.K. researchers to search for drug to fight vCJD

04/13/2005 | Reuters

GlaxoSmithKline plans to work with Britain's Medical Research Council to search for a drug that can be used against the human version of BSE, vCJD. Researchers will screen drug-like molecules in GSK's vast library of compounds in hopes of finding a compound that can enter the brain and bind to the normal prion, preventing it from transforming into an infectious agent.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC